Shares of Milestone Scientific Inc. (NYSE:MLSS - Get Free Report) rose 0.9% during mid-day trading on Wednesday . The stock traded as high as $1.20 and last traded at $1.17. Approximately 57,443 shares traded hands during trading, a decline of 72% from the average daily volume of 202,214 shares. The stock had previously closed at $1.16.
Wall Street Analysts Forecast Growth
MLSS has been the subject of several analyst reports. Benchmark reaffirmed a "speculative buy" rating and set a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th. StockNews.com initiated coverage on shares of Milestone Scientific in a research note on Wednesday, January 29th. They set a "hold" rating for the company.
Check Out Our Latest Stock Analysis on Milestone Scientific
Milestone Scientific Stock Down 4.6 %
The business's 50 day moving average is $1.10 and its two-hundred day moving average is $0.96. The firm has a market cap of $81.01 million, a P/E ratio of -14.86 and a beta of 1.14.
Hedge Funds Weigh In On Milestone Scientific
A number of hedge funds have recently bought and sold shares of MLSS. Y Intercept Hong Kong Ltd bought a new stake in Milestone Scientific in the third quarter valued at $48,000. Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after purchasing an additional 31,572 shares in the last quarter. World Investment Advisors LLC bought a new stake in Milestone Scientific in the third quarter valued at $91,000. Carnegie Investment Counsel increased its stake in Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. Finally, Renaissance Technologies LLC increased its stake in Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares in the last quarter. Institutional investors own 5.79% of the company's stock.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
